Intelligence Platform
Patents
Browse 183 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11918571
Compounds and their methods of use
granted patentUS 11866439
Ion channel modulators
granted patentUS 11866747
Engineered meganucleases that target human mitochondrial genomes
granted patentUS 11851680
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted patentUS 11826392
Purification method of fungal cell wall composition
granted patentUS 11790574
System and method for carbon dioxide angiographic roadmap imaging
granted patentUS 11788141
MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK ce
granted patentUS 11786554
Optimized engineered nucleases having specificity for the human T cell receptor alpha cons
granted patentUS 11788077
Polynucleotides encoding optimized engineered meganucleases having specificity for a recog
granted patentUS 11771723
Bifidobacterium longum NCIMB 41676
granted patentUS 11767325
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted patentUS 11767367
Monoclonal antibody neo-201 for the treatment of human carcinomas
granted patentUS 11753630
Polynucleotides encoding engineered meganucleases having specificity for recognition seque
granted patentUS 11731978
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazol
granted patentUS 11731966
Compounds and their methods of use
granted patentUS 11731976
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazol
granted patentUS 11697669
Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereof
granted patentUS 11679159
Compositions for transfecting resistant cell types
granted patentUS 11680254
Engineered meganucleases specific for recognition sequences in the PCSK9 gene
granted patentUS 11649207
Formulations of T-type calcium channel modulators and methods of use thereof
granted patentUS 11629146
Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity
granted patentUS 11590179
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus
granted patentUS 11572575
Compositions for transfecting resistant cell types
granted patentUS 11572413
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc
granted